The Moat Index
The widest moats in the scored universe.
The 100 widest Healthcare moats — of 737 scored nightly from primary SEC filings, 0–100 on five investor questions. Higher means a more durable business. The method is fully public; the full universe is in the A–Z directory and the sector hubs.
Current score records: moat-index@2.0.0.
The 500 widest Healthcare moats, not just these 100 →
The map — moat vs. price · Healthcare
Dividers sit at Moat Score 80 (a Wide moat) and at 10% below conservative value — the same bars the methodology uses. The x-axis starts at 55 because this set is the top of the Index; the vertical scale is compressed beyond ±25% (every tick shows its true value), and anything priced more than 26× value sits on the "≤ −2500%" line — hover a dot (or open the table) for its exact reading. 22 companies have no recent price data and aren't plotted — the table view lists them.
The 100 widest · Healthcare
| Watchlist | # | Company | Ticker | Sector | Mkt cap | Moat Score | Moat | Price vs. high estimate |
|---|---|---|---|---|---|---|---|---|
| 1 | ALIGN TECHNOLOGY, INC. | ALGN | Healthcare | $12.7B | 98 | Wide moat | 153% above high estimate | |
| 2 | IDEXX LABORATORIES INC /DE | IDXX | Healthcare | $44.0B | 98 | Wide moat | 190% above high estimate | |
| 3 | CORCEPT THERAPEUTICS INC | CORT | Healthcare | $10.1B | 94 | Wide moat | 752% above high estimate | |
| 4 | ResMed Inc. | RMD | Healthcare | $28.7B | 91 | Wide moat | 69% above high estimate | |
| 5 | REGENERON PHARMACEUTICALS, INC. | REGN | Healthcare | — | 90 | Wide moat | No price data | |
| 6 | Intuitive Surgical, Inc. | ISRG | Healthcare | $124.3B | 90 | Wide moat | 284% above high estimate | |
| 7 | Lifevantage Corp | LFVN | Healthcare | $79.5M | 89 | Wide moat | 48% above high estimate | |
| 8 | GARMIN LTD | GRMN | Healthcare | $45.6B | 89 | Wide moat | 96% above high estimate | |
| 9 | IRADIMED CORPORATION | IRMD | Healthcare | $1.2B | 89 | Wide moat | 292% above high estimate | |
| 10 | INNOVIVA, INC. | INVA | Healthcare | $1.6B | 88 | Wide moat | 60% below high estimate | |
| 11 | EDWARDS LIFESCIENCES CORPORATION | EW | Healthcare | $49.1B | 86 | Wide moat | 194% above high estimate | |
| 12 | UTAH MEDICAL PRODUCTS INC | UTMD | Healthcare | $220.3M | 85 | Wide moat | 8% below high estimate | |
| 13 | Waters Corporation | WAT | Healthcare | $21.9B | 85 | Wide moat | 76% above high estimate | |
| 14 | TERADYNE, INC. | TER | Healthcare | $58.4B | 84 | Wide moat | 848% above high estimate | |
| 15 | MIMEDX GROUP, INC. | MDXG | Healthcare | $639.8M | 84 | Wide moat | 36% above high estimate | |
| 16 | SIGA Technologies, Inc. | SIGA | Healthcare | $256.4M | 83 | Wide moat | 61% below high estimate | |
| 17 | BADGER METER, INC. | BMI | Healthcare | $5.4B | 83 | Wide moat | 201% above high estimate | |
| 18 | WEST PHARMACEUTICAL SERVICES, INC. | WST | Healthcare | $25.9B | 83 | Wide moat | 145% above high estimate | |
| 19 | EXELIXIS, INC. | EXEL | Healthcare | $14.7B | 83 | Wide moat | 254% above high estimate | |
| 20 | SBC Medical Group Holdings Incorporated | SBC | Healthcare | $305.7M | 83 | Wide moat | 43% below high estimate | |
| 21 | PACIFIC HEALTH CARE ORGANIZATION, INC. | PFHO | Healthcare | $10.6M | 82 | Wide moat | 5% above high estimate | |
| 22 | Electromed, Inc. | ELMD | Healthcare | $338.3M | 82 | Wide moat | 494% above high estimate | |
| 23 | UNITED THERAPEUTICS Corp | UTHR | Healthcare | $23.4B | 81 | Wide moat | 32% above high estimate | |
| 24 | biote Corp. | BTMD | Healthcare | — | 80 | Wide moat | No price data | |
| 25 | NATURES SUNSHINE PRODUCTS INC | NATR | Healthcare | $365.2M | 80 | Narrow moat | 100% above high estimate | |
| 26 | AGILENT TECHNOLOGIES, INC. | A | Healthcare | $37.6B | 80 | Narrow moat | 62% above high estimate | |
| 27 | HARMONY BIOSCIENCES HOLDINGS, INC. | HRMY | Healthcare | $2.1B | 80 | Narrow moat | 14% above high estimate | |
| 28 | BIOGEN INC. | BIIB | Healthcare | $29.8B | 79 | Narrow moat | 40% above high estimate | |
| 29 | GLOBUS MEDICAL, INC. | GMED | Healthcare | — | 79 | Narrow moat | No price data | |
| 30 | KEYSIGHT TECHNOLOGIES, INC. | KEYS | Healthcare | — | 79 | Narrow moat | No price data | |
| 31 | CATALYST PHARMACEUTICALS, INC. | CPRX | Healthcare | $3.9B | 78 | Narrow moat | 106% above high estimate | |
| 32 | Cognex Corporation | CGNX | Healthcare | $10.5B | 78 | Narrow moat | 593% above high estimate | |
| 33 | LEMAITRE VASCULAR, INC. | LMAT | Healthcare | $2.3B | 78 | Narrow moat | 285% above high estimate | |
| 34 | VERALTO CORPORATION | VLTO | Healthcare | $22.4B | 77 | Narrow moat | 124% above high estimate | |
| 35 | LONGDUODUO COMPANY LIMITED | LDDD | Healthcare | $15.3M | 76 | Narrow moat | No price data | |
| 36 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Healthcare | $122.4B | 76 | Narrow moat | 105% above high estimate | |
| 37 | Illumina, Inc. | ILMN | Healthcare | $29.5B | 76 | Narrow moat | No price data | |
| 38 | TACTILE SYSTEMS TECHNOLOGY INC | TCMD | Healthcare | $637.9M | 76 | Narrow moat | 169% above high estimate | |
| 39 | GILEAD SCIENCES, INC. | GILD | Healthcare | $161.7B | 75 | Narrow moat | 17% above high estimate | |
| 40 | OPTEX SYSTEMS HOLDINGS, INC. | OPXS | Healthcare | $86.0M | 75 | Narrow moat | 242% above high estimate | |
| 41 | Viemed Healthcare, Inc. | VMD | Healthcare | $453.2M | 75 | Narrow moat | 298% above high estimate | |
| 42 | NORTHROP GRUMMAN CORP /DE/ | NOC | Healthcare | $72.7B | 74 | Narrow moat | 10% above high estimate | |
| 43 | DEXCOM, INC. | DXCM | Healthcare | $28.8B | 74 | Narrow moat | 195% above high estimate | |
| 44 | VYCOR MEDICAL, INC. | VYCO | Healthcare | $2.3M | 74 | Narrow moat | No price data | |
| 45 | AMETEK, Inc. | AME | Healthcare | $54.4B | 73 | Narrow moat | 100% above high estimate | |
| 46 | ENSIGN GROUP, INC | ENSG | Healthcare | $9.9B | 73 | Narrow moat | 145% above high estimate | |
| 47 | Elite Pharmaceuticals, Inc. | ELTP | Healthcare | $409.3M | 72 | Narrow moat | 283% above high estimate | |
| 48 | ONTO INNOVATION INC. | ONTO | Healthcare | $14.9B | 72 | Narrow moat | 582% above high estimate | |
| 49 | LANTHEUS HOLDINGS, INC. | LNTH | Healthcare | $7.0B | 72 | Narrow moat | 169% above high estimate | |
| 50 | BillionToOne, Inc. | BLLN | Healthcare | $2.8B | 72 | Narrow moat | No price data | |
| 51 | USANA HEALTH SCIENCES, INC. | USNA | Healthcare | $404.4M | 72 | Narrow moat | 43% below high estimate | |
| 52 | SANUWAVE Health, Inc. | SNWV | Healthcare | $52.1M | 72 | Narrow moat | No price data | |
| 53 | PRO-DEX, INC. | PDEX | Healthcare | $182.7M | 71 | Narrow moat | 64% above high estimate | |
| 54 | EMBECTA CORP. | EMBC | Healthcare | $197.1M | 71 | Narrow moat | 86% below high estimate | |
| 55 | ABBOTT LABORATORIES | ABT | Healthcare | $173.2B | 71 | Narrow moat | 14% above high estimate | |
| 56 | CHAMPIONS ONCOLOGY, INC. | CSBR | Healthcare | $84.0M | 71 | Narrow moat | 1989% above high estimate | |
| 57 | Prestige Consumer Healthcare Inc. | PBH | Healthcare | $2.3B | 70 | Narrow moat | 38% below high estimate | |
| 58 | Indivior Pharmaceuticals, Inc. | INDV | Healthcare | $5.1B | 70 | Narrow moat | No price data | |
| 59 | CHEMED CORPORATION | CHE | Healthcare | $6.9B | 70 | Narrow moat | 132% above high estimate | |
| 60 | MSA Safety Inc | MSA | Healthcare | $6.6B | 70 | Narrow moat | 100% above high estimate | |
| 61 | HALOZYME THERAPEUTICS, INC. | HALO | Healthcare | $9.3B | 70 | Narrow moat | 60% above high estimate | |
| 62 | TRANE TECHNOLOGIES PLC | TT | Healthcare | — | 70 | Narrow moat | No price data | |
| 63 | Privia Health Group, Inc. | PRVA | Healthcare | $3.3B | 70 | Narrow moat | 1935% above high estimate | |
| 64 | Rockwell Automation, Inc. | ROK | Healthcare | $52.2B | 69 | Narrow moat | 350% above high estimate | |
| 65 | FITLIFE BRANDS, INC. | FTLF | Healthcare | $99.4M | 69 | Narrow moat | 65% above high estimate | |
| 66 | Vontier Corporation | VNT | Healthcare | $4.3B | 69 | Narrow moat | 32% below high estimate | |
| 67 | National Vision Holdings, Inc. | EYE | Healthcare | $1.6B | 68 | Narrow moat | 236% above high estimate | |
| 68 | Amgen Inc. | AMGN | Healthcare | $197.3B | 67 | Narrow moat | 32% above high estimate | |
| 69 | NEUROCRINE BIOSCIENCES, INC. | NBIX | Healthcare | $17.9B | 67 | Narrow moat | 378% above high estimate | |
| 70 | Shoulder Innovations, Inc. | SI | Healthcare | $429.0M | 67 | Narrow moat | No price data | |
| 71 | CARLSMED, INC. | CARL | Healthcare | $306.0M | 67 | Narrow moat | No price data | |
| 72 | UNIVERSAL HEALTH SERVICES, INC. | UHS | Healthcare | $9.7B | 67 | Narrow moat | 46% below high estimate | |
| 73 | NOVAVAX, INC. | NVAX | Healthcare | $1.3B | 66 | Narrow moat | No price data | |
| 74 | U S PHYSICAL THERAPY INC /NV | USPH | Healthcare | — | 66 | Narrow moat | No price data | |
| 75 | LIGAND PHARMACEUTICALS INCORPORATED | LGND | Healthcare | $6.0B | 66 | Narrow moat | 538% above high estimate | |
| 76 | STRYKER CORP | SYK | Healthcare | — | 66 | Narrow moat | No price data | |
| 77 | Penumbra, Inc | PEN | Healthcare | $12.5B | 66 | Narrow moat | 6678% above high estimate | |
| 78 | AbbVie Inc. | ABBV | Healthcare | $452.9B | 65 | Narrow moat | 219% above high estimate | |
| 79 | Medinotec Inc. | MDNC | Healthcare | — | 65 | Narrow moat | No price data | |
| 80 | NATIONAL HEALTHCARE CORP | NHC | Healthcare | $3.5B | 65 | Narrow moat | 65% above high estimate | |
| 81 | BETA BIONICS, INC. | BBNX | Healthcare | $781.6M | 65 | Narrow moat | No price data | |
| 82 | STERIS plc | STE | Healthcare | $20.7B | 65 | Narrow moat | 97% above high estimate | |
| 83 | IRONWOOD PHARMACEUTICALS, INC. | IRWD | Healthcare | $637.6M | 65 | Narrow moat | 129% above high estimate | |
| 84 | Omada Health, Inc. | OMDA | Healthcare | $1.3B | 65 | Narrow moat | No price data | |
| 85 | Leonardo DRS, Inc. | DRS | Healthcare | $12.1B | 64 | Narrow moat | 207% above high estimate | |
| 86 | Alpha Pro Tech, Ltd. | APT | Healthcare | $52.1M | 64 | Narrow moat | 19% above high estimate | |
| 87 | Gyre Therapeutics, Inc. | GYRE | Healthcare | $553.4M | 64 | Narrow moat | 1054% above high estimate | |
| 88 | FUNCTIONAL BRANDS INC. | MEHA | Healthcare | $93523 | 64 | Narrow moat | 93% below high estimate | |
| 89 | Neuraxis, INC | NRXS | Healthcare | $74.7M | 64 | Narrow moat | No price data | |
| 90 | ZIMMER BIOMET HOLDINGS, INC. | ZBH | Healthcare | $17.4B | 64 | Narrow moat | Around the high estimate | |
| 91 | TELEDYNE TECHNOLOGIES INC | TDY | Healthcare | $29.9B | 64 | Narrow moat | 59% above high estimate | |
| 92 | DELCATH SYSTEMS, INC. | DCTH | Healthcare | $444.4M | 63 | Narrow moat | No price data | |
| 93 | SOLVENTUM CORPORATION | SOLV | Healthcare | $13.6B | 62 | Narrow moat | 25% below high estimate | |
| 94 | CODA OCTOPUS GROUP, INC. | CODA | Healthcare | $114.7M | 62 | Narrow moat | 54% above high estimate | |
| 95 | 3M COMPANY | MMM | Healthcare | $90.6B | 62 | Narrow moat | 87% above high estimate | |
| 96 | Krystal Biotech, Inc. | KRYS | Healthcare | $9.9B | 62 | Narrow moat | 8049% above high estimate | |
| 97 | THERMO FISHER SCIENTIFIC INC. | TMO | Healthcare | $194.5B | 62 | Narrow moat | 68% above high estimate | |
| 98 | UFP Technologies, Inc. | UFPT | Healthcare | $1.9B | 62 | Narrow moat | 128% above high estimate | |
| 99 | HIMS & HERS HEALTH, INC. | HIMS | Healthcare | $8.5B | 62 | Narrow moat | No price data | |
| 100 | MOVADO GROUP, INC. | MOV | Healthcare | $857.5M | 62 | Narrow moat | 80% above high estimate |